https://orcid.org/0000-0002-3339-6203
References
- Kretchy IA, Asiedu-Danso M, Kretchy JP. Medication management and adherence during the COVID-19 pandemic: perspectives and experiences from low-and middle-income countries. Res Social Adm Pharm. 2020.
- Source: “Choosing Wisely COVID-19 Recommendations.” Choosing Wisely Canada, 30 Apr. 2020, choosingwiselycanada.org/covid-19/. [Accessed May 12, 2020].
- Kane-GillSL,NiznikJD,KellumJA,et al.Use of telemedicine to enhance pharmacist Services in the Nursing Facility.Consult Pharm.2017;32(2):93–8.
- AbughoshSM,WangX,SernaO,et al.A pharmacist telephone intervention to identify adherence barriers and improve adherence among nonadherent patients with comorbid hypertension and diabetes in a Medicare advantage plan.J Manag Care Spec Pharm.2016;22(1):63–73.
- SuksomboonN,PoolsupN,NgeYL.Impact of phone call intervention on glycemic control in diabetes patients: a systematic review and meta-analysis of randomized, controlled trials.PLoS One.2014;9(2):e89207.
- Ho JM, Tung J, Maitland J, et al. GeriMedRisk, a telemedicine geriatric pharmacology consultation service to address adverse drug events in long-term care: a stepped-wedge cluster randomized feasibility trial protocol (ISRCTN17219647). Pilot Feasibility Stud. 2018;4:116.
- RajkumarRP.COVID-19 and mental health: a review of the existing literature.Asian J Psychiatr.2020;52:102066.
- WuC,BellCM,WodchisWP.Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study.Drug Saf.2012;35(9):769–81.
- Phizackerley D. Deprescribing in the time of covid-19. Drug Ther Bull. 2020. https://pubmed.ncbi.nlm.nih.gov/32354724/?from_term=Phizackerley%2C+David%5Bauthor%5D&from_pos=7.
- PageAT,CliffordRM,PotterK,SchwartzD,Etherton-BeerCD.The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.Br J Clin Pharmacol.2016;82(3):583–623.